🌱 KidneyEnergy.com

← brief for 2026-11-15 · Slowing decline

Comparative risk of acute kidney injury in oncology patients receiving vancomycin monotherapy versus vancomycin with piperacillin-tazobactam: a retrospective cohort study

Article C Peer reviewed Observational

Key takeaways

This study looked at cancer patients taking two common antibiotics. It compared taking vancomycin alone versus taking it with piperacillin-tazobactam. The study is observational, so it shows a link but not proof of cause. It helps doctors weigh the risk of kidney injury from these drugs.

Who did this work

Dana Sadaqa (Augusta Victoria Hospital) · Mohammad Yaish (Augusta Victoria Hospital) · Ibrahim Bsharat (Augusta Victoria Hospital) · Hasan Arafat (Augusta Victoria Hospital) · Ayman Shoibat (Augusta Victoria Hospital) · Hammam Rjoup (Augusta Victoria Hospital) · Hamza Alsaid (Hadassah Medical Center) · Ali Sabateen (Augusta Victoria Hospital)

Source

Article · OpenAlex, Kidney disease concept sweep (verified C2778653478) · 2026-11-14
https://doi.org/10.1186/s40360-026-01284-z